HIGHLIGHTS
- who: Stellee M. P. Biscaia and colleagues from the Department of Cellular Biology, Federal University of Paraná (UFPR), Curitiba, Brazil have published the article: MG-Pe: A Novel Galectin-3 Ligand with Antimelanoma Properties and Adjuvant Effects to Dacarbazine, in the Journal: (JOURNAL)
- what: Study, the authors investigated MG-Pe treatment versus dacarbazine (DTIC-chemotherapy agent in this study, the authors investigated MG-Pe treatment versus dacarbazine (DTIC-chemotherwith known antitumor effect), alone or in combination (adjuvant effect). Treatments that reduce the metastatic potential of tumor cells are of great interest and one of the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.